New pill tested to boost Insulin's power against diabetes
NCT ID NCT02081599
Summary
This study tested whether adding a pill called teneligliptin to insulin therapy helps control blood sugar better in Japanese adults with type 2 diabetes. It involved 148 participants who were already on a stable insulin dose. Researchers measured changes in key blood sugar markers over 16 weeks, with some participants continuing for up to a year to check long-term safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Chuo-ku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.